- Home
- / Innocan Pharma
Innocan Pharma
Stock Price
$0.2
2024-10-29
Market Capitalization
$65.7 M
2024-10-29
Revenue
$26.6 M
FY, 2025
Innocan Pharma Summary
Company Summary
- Overview
- Innocan Pharma is a pharmaceutical tech company that specializes in the development of drug delivery platforms. It offers eye serums, face creams and glow oils, recovery lotion, relief and go sprays, and other products. The company also sells CBD-integrated pharmaceuticals.
- Type
- Public
- Status
- Active
- Founded
- 2018
- Website
- https://innocanpharma.com/
- Cybersecurity rating
Table of Contents
Innocan Pharma Financials
Summary Financials
- Revenue (FY, 2025)
- $26.6M
- Gross profit (FY, 2025)
- $24.0M
- Net income (FY, 2025)
- ($341.0K)
- Cash (FY, 2025)
- $6.7M
- EBIT (FY, 2025)
- $58.0K
- Enterprise value
- $60.0M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026